Bebtelovimab-bound SARS-CoV-2 RBD mutants: resistance profiling and validation with escape mutations, clinical results, and viral genome sequences.

bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/39107909

Aditya K Padhi; Amar Jeet Yadav; Khushboo Bhagat; Shweata Maurya; Timir Tripathi

Aug 7, 2024